Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

202.00 USD -2.14 (-1.05%)
Official Closing Price Updated: 4:19 PM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Leerink Presents: Your 2017 Biopharma Catalyst Tracker
In its biopharma catalysts tracker released March 1, Leerink termed the year 2017 as a busy one for Neuro and Oncology. The firm ... 
Tags MRK SHPG REGN
From Benzinga
UPDATE 1-Lilly's breast cancer drug combination succeeds key study
March 20 (Reuters) - Eli Lilly and Co said a combination of its experimental breast cancer drug and another widely used treatment slowed disease progression in a key study in patients who had relapsed... 
Tags companyNews
From Reuters: Company News
BRIEF-Lilly says phase 3 breast cancer study meets primary endpoint
* Lilly announces phase 3 monarch 2 breast cancer study of abemaciclib met primary endpoint of progression-free survival 
Tags companyNews
From Reuters: Company News
REFILE-Newer type 2 diabetes drugs show heart protective quality in study
WASHINGTON, March 19 (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease,... 
Tags companyNews
From Reuters: Company News
Cramer's lightning round: Target's caught between these two retailers, and it could get hairy
Jim Cramer sped through his takes on caller favorite stocks, including Target, which is in a tough spot. 
Tags Investing/Stock Market Investing Eli Lilly and Co
From CNBC.com News
BRIEF-First dedicated outcome trials of empagliflozin in chronic heart failure initiated
* First dedicated outcome trials of Empagliflozin in chronic heart failure initiated 
Tags companyNews
From Reuters: Company News
IWV, PCLN, CVS, LLY: Large Outflows Detected at ETF
Symbols mentioned in this story: IWV, PCLN, CVS, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Here's Why Aratana Therapeutics Inc. Is Getting Clobbered
Tags LLY PETX
From Motley Fool
Pfizer Inc. Suddenly Faces Stiff Breast Cancer Drug Competition From Novartis
Pfizer Inc. had been just the only player in a very specific breast cancer treatment game, but now Novartis has entered the race with a brand new drug that could be a blockbuster and threaten Pfizer’s... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Better Buy: Eli Lilly and Company vs. Pfizer
Tags LLY PFE
From Motley Fool
Lilly, Merck, Allergan Top Analyst's View For 2017 Pharma
Eli Lilly, Merck and Allergan stand to outperform broad pharma stocks in 2017, a Credit Suisse analyst said Monday. 
Tags Technology
From Investor's Business Daily
How Incyte Stock Became a Bull Market Star for Biotech Investors
Despite many twists and turns, the U.S. stock market has had a stupendous run since it reached a bottom in Mar 2009. The bull run has continued for eight years with the S&P 500 gaining 198.1% during... 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to Know
Tags INCY MRK LLY
From Motley Fool
Feds cause standstill for promising marijuana cure for Alzheimer's
Promising new research suggests that marijuana could be used to treat Alzheimer's, but there's a major roadblock: the federal government. 
Tags Health Care Health Care/Pharmaceuticals Biotechnology and Life Sciences Biotechnology
From CNBC.com News
This Pharma Firm Is Beating The Pack In Getting Drugs To Market
Lilly's pipeline has the best "bang-for-the-buck," Leerink said Wednesday, pitting Lilly against larger rivals Pfizer, Merck and Bristol. 
Tags Technology
From Investor's Business Daily
INSIGHT-"It's like kumbaya:" Trump's genial private meetings with CEOs jar with public attacks
WASHINGTON, March 8 (Reuters) - When the bosses of some of the world's largest pharmaceutical companies headed to Washington in January to meet U.S. President Donald Trump, it had all the makings of a... 
Tags companyNews
From Reuters: Company News
Trump’s ‘Obamacare Lite’ presents opportunities and perils for investors
Health-care insurers and medical-device companies would benefit. Also, expect a wave of M&A, writes Nigam Arora. 
Tags BSX DIA VNDA
From MarketWatch
PPH, LLY, GSK, SNY: Large Outflows Detected at ETF
Symbols mentioned in this story: PPH, LLY, GSK, SNY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Week In Review: OrbiMed Plans $450 Million Target For Third Asia Life Science Fund
OrbiMed filed with the SEC to raise $450 million for its third Asia-focused fund, OrbiMed Asia Partners III. The company says it considers investments in all sectors of life science. 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
Chi-Med's Lead Candidate Passes Phase III Colorectal Cancer Test
Hutchison China MediTech (Chi-Med) reported that its lead drug, fruquintinib, met its endpoints in a pivotal Phase III China trial. Fruquintinib was tested as a third-line treatment for metastatic... 
From ChinaBio® Today
BRIEF-Eli Lilly says senior VP of corporate affairs and communications to leave
* Eli Lilly and Co - Johna Norton will be promoted to senior vice president of global quality April 1, replacing Fionnuala Walsh 
Tags companyNews
From Reuters: Company News
Cramer’s charts uncover 4 pharma stocks ready to explode higher
Jim Cramer went off the charts with Bob Lang to determine if pharma has more room to run. 
Tags Eli Lilly and Co Investing Investing/Stock Market
From CNBC.com News
Icahn, after break from biopharma activism, hires Harvard geneticist Richard Mulligan
The hire signals Carl Icahn may be back to biopharma investing, at a time when biotech valuations are 25 percent off their 2015 highs. 
Tags People/Newsmakers/Carl Icahn Health Care Biotechnology
From CNBC.com News
BRIEF-Perrigo announces FDA final approval for the generic version of Axiron topical solution
* Perrigo announces FDA final approval for the generic version of Axiron topical solution, 30 mg/1.5 ml Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
Accera's Alzheimer's trial fails, in yet another setback for disease
Feb 28 (Reuters) - Nestle SA-backed Accera Inc said on Tuesday its experimental Alzheimer's drug failed a late-stage study, adding to the laundry list of disappointments in the pursuit of an effective... 
Tags companyNews
From Reuters: Company News
Roche to start new trial of AC Immune drug against Alzheimer's
ZURICH, Feb 28 (Reuters) - Roche is starting a second late-stage trial of investigational Alzheimer's drug crenezumab that it is developing with Swiss biotech AC Immune , shrugging off failures of... 
Tags companyNews
From Reuters: Company News
Overview of Vanguard Capital Opportunity Investor Fund (VHCOX)
Vanguard Capital Opportunity Investor invests primarily in stocks of mid- and small-capitalization companies expected to have above-average earnings growth. 
Tags Healthcare Stocks / Equities Mutual Funds
From Blogs - TalkMarkets
Better Buy: Eli Lilly and Co vs. GlaxoSmithKline plc
Tags GSK LLY
From Motley Fool
BRIEF-FTC approves final order settling charges for Boehringer Ingelheim’s asset swap with Sanofi
* U.S. FTC - Approved final order settling charges that Boehringer Ingelheim’s $13.53 billion asset swap with Sanofi would likely be anticompetitive Source text : (http://bit.ly/2lC10ws) Further... 
Tags companyNews
From Reuters: Company News
Carl Icahn's Track Record In Big Pharma
Billionaire investor and corporate raider Carl Icahn has trained his eyes on Bristol-Myers Squibb Co (NYSE: BMY). A Wall Street ... 
Tags General News RHHBY
From Benzinga
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.